XML 43 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information (Tables)
6 Months Ended
Jun. 30, 2021
Segment Reporting [Abstract]  
Financial Data By Reportable Segment
Financial data by reportable segment for the three and six months ended June 30, 2021 and 2020 is as follows:
Commercial
& Specialty
Business
Government
Business
IngenioRxOtherEliminationsTotal
Three Months Ended June 30, 2021
Operating revenue - unaffiliated$9,550 $20,066 $3,042 $621 $— $33,279 
Operating revenue - affiliated— — 3,177 1,896 (5,073)— 
Operating gain791 868 405 17 — 2,081 
Three Months Ended June 30, 2020
Operating revenue - unaffiliated$8,789 $17,242 $2,544 $603 $— $29,178 
Operating revenue - affiliated— — 2,725 849 (3,574)— 
Operating gain1,372 1,618 304 66 — 3,360 
Six Months Ended June 30, 2021
Operating revenue - unaffiliated$19,041 $39,349 $5,780 $1,207 $— $65,377 
Operating revenue - affiliated— — 6,301 3,680 (9,981)— 
Operating gain2,059 1,346 812 25 — 4,242 
Six Months Ended June 30, 2020
Operating revenue - unaffiliated$18,150 $34,708 $4,887 $881 $— $58,626 
Operating revenue - affiliated— — 5,579 1,598 (7,177)— 
Operating gain2,792 2,029 653 80 — 5,554 
Major Product Revenue by Segment
The major product revenues for each of the reportable segments for the three and six months ended June 30, 2021 and 2020 are as follows:
Three Months Ended 
 June 30
Six Months Ended 
 June 30
2021202020212020
Commercial & Specialty Business
Managed care products
$7,772 $7,132 $15,461 $14,700 
Managed care services
1,416 1,263 2,802 2,645 
Dental/Vision products and services
335 284 671 599 
Other
27 110 107 206 
Total Commercial & Specialty Business
9,550 8,789 19,041 18,150 
Government Business
Managed care products
19,965 17,149 39,147 34,524 
Managed care services
101 93 202 184 
Total Government Business
20,066 17,242 39,349 34,708 
IngenioRx
Pharmacy products and services6,219 5,269 12,081 10,466 
Total IngenioRx
6,219 5,269 12,081 10,466 
Other
Integrated health services2,366 1,376 4,615 2,325 
Other
151 76 272 154 
Total Other Business2,517 1,452 4,887 2,479 
Eliminations
Eliminations
(5,073)(3,574)(9,981)(7,177)
Total product revenues
$33,279 $29,178 $65,377 $58,626 
Reconciliation Of Reportable Segments Operating Revenues To Total Revenues Reported In The Consolidated Statements Of Income
A reconciliation of reportable segments’ operating revenue to the amounts of total revenues included in our consolidated statements of income for the three and six months ended June 30, 2021 and 2020 is as follows:
 Three Months Ended 
 June 30
Six Months Ended 
 June 30
 2021202020212020
Reportable segments’ operating revenue$33,279 $29,178 $65,377 $58,626 
Net investment income400 57 691 311 
Net realized gains (losses) on financial instruments172 29 168 (52)
Total revenues$33,851 $29,264 $66,236 $58,885 
Reconciliation Of Reportable Segments Operating Gain To Income Before Income Tax Expense Included In The Consolidated Statements Of Income
A reconciliation of reportable segments’ operating gain to income before income tax expense included in our consolidated statements of income for the three and six months ended June 30, 2021 and 2020 is as follows:
 Three Months Ended 
 June 30
Six Months Ended 
 June 30
 2021202020212020
Reportable segments’ operating gain$2,081 $3,360 $4,242 $5,554 
Net investment income400 57 691 311 
Net realized gains (losses) on financial instruments172 29 168 (52)
Interest expense(205)(201)(397)(395)
Amortization of other intangible assets(90)(93)(170)(176)
Loss on extinguishment of debt(5)(3)(5)(4)
Income before income tax expense$2,353 $3,149 $4,529 $5,238